Osteoporosis and osteoblast differentiation in mouse models of accelerated aging

加速衰老小鼠模型中的骨质疏松症和成骨细胞分化

基本信息

  • 批准号:
    7627958
  • 负责人:
  • 金额:
    $ 31.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A fundamental aspect of age-related bone loss is the decreased proliferative capacity and impaired differentiation of osteoblasts in the bone of older individuals. Telomeres shorten with age in most human tissues, including bone, and since telomere shortening is a cause of cellular replicative senescence in cultured cells, including osteoblasts and mesenchymal stem cells (MSCs), it is likely that telomere status in MSCs is a critical component of bone formation. Osteoporosis is common in the Werner (Wrn) and Dyskeratosis congenita (DC) premature aging syndromes. One of the targets of the Wrn helicase is telomeric DNA, but the long telomeres and abundant telomerase in mice minimize the need for WRN at telomeres, and thus Wrn knockout mice are healthy. In a model of accelerated aging that combines the Wrn mutation with the shortened telomeres of telomerase (Terc) knockout mice, synthetic defects in proliferative tissues, including bone, have been observed. It is hypothesized that deficiencies in genome maintenance molecules such as TERC and WRN cause a low bone mass phenotype and microarchitectural abnormalities of bone by impairing the ability of MSCs to differentiate into osteoblasts. It is further hypothesized that effective osteoblast differentiation depends on the presence of functional MSCs and hematopoietic stem cells (HSCs). Using micro-CT analysis and bone histomorphometry, this proposal will establish the relationship between the WRN and TERC molecules and structural bone fidelity, including microarchitecture and bone density. We will determine if age-related bone abnormalities in Wrn-/-, Terc-/- and Wrn -/- Terc-/- mice are related to deficiencies in osteoblast differentiation and/or increased osteoclastogenic potential, and will examine whether anabolic defects due to MSC impairment in mutant mice are associated with replicative senescence and/or telomere shortening/uncapping. We will also assess the contributions of MSCs and HSCs to osteoblast differentiation by selective and nonselective bone marrow transplantation of these cellular progenitors and analysis of their ability to reduce age-related osteoporotic changes. A consequence and major clinical challenge in the elderly is osteoporosis and associated high risk of fracture. The Wrn-/-Terc -/- mutant mouse recapitulates senile osteoporosis characterized by decreased bone-forming capacity and provides a system to test stem cell replacement for amelioration of age-related osteoporosis.
描述(由申请人提供):与年龄相关的骨质流失的一个基本方面是老年人骨骼中成骨细胞的增殖能力降低和分化受损。在大多数人体组织(包括骨骼)中,端粒会随着年龄的增长而缩短,并且由于端粒缩短是培养细胞(包括成骨细胞和间充质干细胞(MSC))中细胞复制衰老的原因,因此 MSC 中的端粒状态可能是骨形成的关键组成部分。骨质疏松症常见于沃纳 (Wrn) 和先天性角化不良 (DC) 早衰综合征。 Wrn解旋酶的目标之一是端粒DNA,但小鼠体内的长端粒和丰富的端粒酶最大限度地减少了端粒对WRN的需求,因此Wrn敲除小鼠是健康的。在将 Wrn 突变与端粒酶 (Terc) 敲除小鼠端粒缩短相结合的加速衰老模型中,观察到包括骨在内的增殖组织的合成缺陷。据推测,TERC 和 WRN 等基因组维护分子的缺陷会损害 MSC 分化为成骨细胞的能力,从而导致低骨量表型和骨微结构异常。进一步假设,有效的成骨细胞分化取决于功能性 MSC 和造血干细胞 (HSC) 的存在。利用显微 CT 分析和骨组织形态计量学,该提案将建立 WRN 和 TERC 分子与结构骨保真度(包括微结构和骨密度)之间的关系。我们将确定 Wrn-/-、Terc-/- 和 Wrn -/- Terc-/- 小鼠中与年龄相关的骨异常是否与成骨细胞分化缺陷和/或破骨细胞生成潜力增加有关,并将检查突变小鼠中 MSC 损伤导致的合成代谢缺陷是否与复制性衰老和/或端粒缩短/脱帽有关。我们还将通过选择性和非选择性骨髓移植这些细胞祖细胞来评估 MSC 和 HSC 对成骨细胞分化的贡献,并分析它们减少与年龄相关的骨质疏松变化的能力。老年人的一个后果和主要临床挑战是​​骨质疏松症和相关的高骨折风险。 Wrn-/-Terc -/- 突变小鼠概括了以骨形成能力下降为特征的老年骨质疏松症,并提供了一个测试干细胞替代以改善与年龄相关的骨质疏松症的系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT JOHN PIGNOLO其他文献

ROBERT JOHN PIGNOLO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT JOHN PIGNOLO', 18)}}的其他基金

Integrated Healthspan Phenotyping
综合健康寿命表型
  • 批准号:
    10349483
  • 财政年份:
    2019
  • 资助金额:
    $ 31.64万
  • 项目类别:
Integrated Healthspan Phenotyping
综合健康寿命表型
  • 批准号:
    10561626
  • 财政年份:
    2019
  • 资助金额:
    $ 31.64万
  • 项目类别:
Osteoporosis and osteoblast differentiation in mouse models of accelerated aging
加速衰老小鼠模型中的骨质疏松症和成骨细胞分化
  • 批准号:
    7439164
  • 财政年份:
    2007
  • 资助金额:
    $ 31.64万
  • 项目类别:
Osteoporosis and osteoblast differentiation in mouse models of accelerated aging
加速衰老小鼠模型中的骨质疏松症和成骨细胞分化
  • 批准号:
    7265803
  • 财政年份:
    2007
  • 资助金额:
    $ 31.64万
  • 项目类别:
Osteoporosis and osteoblast differentiation in mouse models of accelerated aging
加速衰老小鼠模型中的骨质疏松症和成骨细胞分化
  • 批准号:
    8097457
  • 财政年份:
    2007
  • 资助金额:
    $ 31.64万
  • 项目类别:
Osteoporosis and osteoblast differentiation in mouse models of accelerated aging
加速衰老小鼠模型中的骨质疏松症和成骨细胞分化
  • 批准号:
    7877955
  • 财政年份:
    2007
  • 资助金额:
    $ 31.64万
  • 项目类别:
Histology Core
组织学核心
  • 批准号:
    8380612
  • 财政年份:
    2006
  • 资助金额:
    $ 31.64万
  • 项目类别:
Histology Core
组织学核心
  • 批准号:
    8880861
  • 财政年份:
    2006
  • 资助金额:
    $ 31.64万
  • 项目类别:
Histology Core
组织学核心
  • 批准号:
    8187077
  • 财政年份:
    2006
  • 资助金额:
    $ 31.64万
  • 项目类别:
Histology Core
组织学核心
  • 批准号:
    8681154
  • 财政年份:
    2006
  • 资助金额:
    $ 31.64万
  • 项目类别:

相似海外基金

A randomized, double-blind, placebo-controlled, clinical trial of a probiotic/prebiotic supplement for the dietary management of age-related bone loss.
益生菌/益生元补充剂用于饮食管理与年龄相关的骨质流失的随机、双盲、安慰剂对照临床试验。
  • 批准号:
    10733549
  • 财政年份:
    2023
  • 资助金额:
    $ 31.64万
  • 项目类别:
Doctoral Dissertation Research: Exploring Localized Relationships Between Age-related Bone Loss and Cortical Expansion in Diaphyseal Bone
博士论文研究:探索年龄相关骨丢失与骨干皮质扩张之间的局部关系
  • 批准号:
    2141878
  • 财政年份:
    2022
  • 资助金额:
    $ 31.64万
  • 项目类别:
    Standard Grant
Influence of aging on the preB cell product, λ5, and its contribution to age-related bone loss
衰老对前 B 细胞产物 α5 的影响及其对与年龄相关的骨质流失的贡献
  • 批准号:
    10589513
  • 财政年份:
    2022
  • 资助金额:
    $ 31.64万
  • 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
  • 批准号:
    10208697
  • 财政年份:
    2020
  • 资助金额:
    $ 31.64万
  • 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
  • 批准号:
    10399612
  • 财政年份:
    2020
  • 资助金额:
    $ 31.64万
  • 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
  • 批准号:
    10615740
  • 财政年份:
    2020
  • 资助金额:
    $ 31.64万
  • 项目类别:
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
  • 批准号:
    488140-2016
  • 财政年份:
    2018
  • 资助金额:
    $ 31.64万
  • 项目类别:
    Postdoctoral Fellowships
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
  • 批准号:
    488140-2016
  • 财政年份:
    2017
  • 资助金额:
    $ 31.64万
  • 项目类别:
    Postdoctoral Fellowships
Development of a Wearable Electrical Stimulation Device to Mitigate Age-Related Bone Loss
开发可穿戴电刺激装置以减轻与年龄相关的骨质流失
  • 批准号:
    515665-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 31.64万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Risk Factors for Age Related Bone Loss
年龄相关骨质流失的危险因素
  • 批准号:
    9539088
  • 财政年份:
    2017
  • 资助金额:
    $ 31.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了